Shares of Pfizer (PFE) rose nearly $1 to $44.37 Monday after the world's largest pharmaceutical company said it expects annual earnings growth of 25% or more through 2002 and sees double-digit revenue growth in 2001.
The New York-based firm, whose stable of products includes the cholesterol fighter Lipitor, Celebrex for arthritis and the impotence medication Viagra, also said it remains comfortable with earnings estimates of $1.01 a share for 2000 and $1.27 or better for 2001. For 2002, it said it was comfortable with estimates of $1.56 a share or better.
